StockVS

NASDAQ · Health Information Services · USD

Zhongchao Inc. (ZCMD) Stock Analysis

Zhongchao Inc. (ZCMD) is a Health Information Services stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

ZCMD

$1.34

−$0.07 (−4.96%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare ZCMD with… →

ZCMD Key Statistics

As of Oct 21, 2026
Trading
Open
$1.39
Previous Close
$1.41
Day's Range
1.33–1.44
52-Week Range
1.25–1,443.36
Volume
42.66K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
−0.04
Valuation
Market Cap
$5.95M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.52
EPS (ttm)Profit attributable to each share over the last twelve months.
−344.10
Financials (FY)
Revenue (FY)
$11.37M−28.30%
Net Income (FY)
−$6.31M
Profit marginThe share of revenue left as profit after all costs and taxes.
−55.47%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
4.33M
1-Year Return
−99.76%
Dividend and dates
Avg Volume
2.42M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, ZCMD closed at $1.34, −99.76% over 1 year.

Zhongchao Inc. (ZCMD) has a market capitalization of $5.95M.

In fiscal 2025, ZCMD reported revenue of $11.37M.

ZCMD Stock Return by Calendar Year

Zhongchao Inc. (ZCMD) return since Feb 2020: what $10,000 became

1 year
$10,000 $24
−99.76%
5 years
$10,000 $1
−99.99%
Since Feb 2020
$10,000 $0.45
−99.996%

If you had invested $10,000 in Zhongchao Inc. (ZCMD) at the close on February 25, 2020, the earliest close on record here, it would have been worth $0.45 at the close on October 21, 2026: −99.996% in total, −77.81% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−99.60%
2025−72.22%
2024−53.85%
2023−69.45%
2022−35.45%
2021+4.71%
2020 (partial year)−57.82%

As of October 21, 2026.

ZCMD Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$11.37M−$6.31M−55.5%
2024$15.86M−$643.23K−4.1%
2023$19.43M−$11.34M−58.3%
2022$14.15M−$2.94M−20.8%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$11.37M$5.12M−$6.19M−$6.31M−55.5%
2024$15.86M$8.91M−$341.27K−$643.23K−4.1%
2023$19.43M$8.51M−$5.41M−$11.34M−58.3%
2022$14.15M$6.36M−$2.95M−$2.94M−20.8%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

ZCMD Valuation vs Health Information Services Median

Median of 44 stocks
MetricZCMDHealth Information Services medianvs median
P/S ratio0.522.310.2x the median
Profit margin−55.47%−7.55%47.9 pts below

Medians across 44 Health Information Services stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Zhongchao Inc. (ZCMD) is capitalised at $5.95M on the latest close. It is classified in the Health Information Services industry, within the Healthcare sector. Headcount on file is 33.

The 52-week range on file runs from $1.25 to $1,443.36. The most recent close on file for ZCMD is $1.34, dated October 21, 2026. That is −$0.07 (−4.96%) against the previous close. The latest close sits 6.94% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $11.37M. Against the prior fiscal year total of $15.86M, that is a change of −28.30%. The same year closed with a net loss of $6.31M. The reported profit margin is −55.47%. That is 47.9 percentage points below the Health Information Services median of −7.55%. Earnings per share on a trailing basis come to −344.1.

Across the 4 fiscal years on file, revenue moves from $14.15M in 2022 to $11.37M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The price-to-sales ratio is 0.52. On price-to-sales that is 0.2 times the Health Information Services median of 2.31. The medians here are taken across 44 Health Information Services companies that report the metric.

Over the trailing twelve months the total return is −99.76%. Across 5 years the annualized return works out at −83.95%. The reported beta is −0.04. Annualized volatility over the trailing 6 years is 152.58%.

Growth & Income

The record shows no dividend for ZCMD.

2026 is still running; the total return is −99.60% year to date. Across the complete calendar years on file, 2021 returned +4.71% and 2025 returned −72.22%. Of the 5 complete calendar years on file, 1 finished higher.

Peer Comparison

Zhongchao Inc. (ZCMD) operates in the Health Information Services industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Zhongchao Inc. ZCMD $5.95M —
Veeva Systems Inc. VEEV $51.90B 52.6
BrightSpring Health Services, Inc. BTSG $12.40B 55.4
Tempus AI, Inc. TEM $12.23B —

The Health Information Services industry average P/E ratio is 46.5x. Zhongchao Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Health Information Services Stocks

View all Health Information Services stocks →

Popular Healthcare Stocks

View all Healthcare stocks →

About Zhongchao Inc.

Zhongchao Inc. provides healthcare information, education, and training services to healthcare professionals under their MDMOOC brand in the People's Republic of China. It operates through two segments, MDMOOC services, and Sales of Patented Drugs. The company offers patient management services in the tumor and rare diseases field, internet healthcare services, and pharmaceutical services, and operates an online information platform. It also provides online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes on popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content. The company offers its services through its MDMOOC online platform, such as the MDMOOC mobile app, MOOC Medical WeChat subscription account, and MDMOOC website, and patient management services through an IT system under the Zhongxun brand, WeChat mini program, and Zhongxin Health WeChat mini program. It serves pharmaceutical enterprises and non-profit organizations, including medical associations, medical institutions, medical journals, medical foundations, and hospitals, as well as healthcare professionals, nurses, and doctors. Zhongchao Inc. was founded in 2012 and is headquartered in Shanghai, China.

Visit website →